カテゴリ： QYResearch, 世界, 医療/バイオ

ペット予防医薬品の世界市場2023年：粉末、液体

■ 英語タイトル：Global Preventive Medicine for Pets Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA6651）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA6651
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ペット予防医薬品の世界市場2023年：粉末、液体]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はペット予防医薬品のグローバル市場について調査・分析し、世界のペット予防医薬品市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（粉末、液体）、用途別セグメント分析（猫、犬、爬虫類、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Wuhan chopperlvya、CAHICなどが含まれています。ペット予防医薬品のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ペット予防医薬品市場規模を算出する際に考慮しました。

・ペット予防医薬品市場の概要
- 製品の定義
- ペット予防医薬品の種類別セグメント
- 世界のペット予防医薬品市場規模：タイプ別分析（粉末、液体）
- ペット予防医薬品の用途別セグメント
- 世界のペット予防医薬品市場規模：用途別分析（猫、犬、爬虫類、その他）
- 世界のペット予防医薬品市場規模予測（2018年-2029年）
- ペット予防医薬品の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ペット予防医薬品市場の競争状況およびトレンド

・ペット予防医薬品の地域別市場規模
- 北米のペット予防医薬品市場規模（2018年-2029年）
- 米国のペット予防医薬品市場規模（2018年-2029年）
- ヨーロッパのペット予防医薬品市場規模（2018年-2029年）
- アジア太平洋のペット予防医薬品市場規模（2018年-2029年）
- 中国のペット予防医薬品市場規模（2018年-2029年）
- 日本のペット予防医薬品市場規模（2018年-2029年）
- 韓国のペット予防医薬品市場規模（2018年-2029年）
- インドのペット予防医薬品市場規模（2018年-2029年）
- オーストラリアのペット予防医薬品市場規模（2018年-2029年）
- 中南米のペット予防医薬品市場規模（2018年-2029年）
- 中東・アフリカのペット予防医薬品市場規模（2018年-2029年）

・種類別セグメント：粉末、液体
- 世界のペット予防医薬品のタイプ別販売量（2018年-2023年）
- 世界のペット予防医薬品のタイプ別売上（2018年-2023年）
- 世界のペット予防医薬品のタイプ別価格

・用途別セグメント：猫、犬、爬虫類、その他
- 世界のペット予防医薬品の用途別販売量（2018年-2023年）
- 世界のペット予防医薬品の用途別売上（2018年-2023年）
- 世界のペット予防医薬品の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Wuhan chopperlvya、CAHIC

・産業チェーンと販売チャネルの分析
- ペット予防医薬品産業チェーン分析
- ペット予防医薬品の主要原材料
- ペット予防医薬品の販売チャネル
- ペット予防医薬品のディストリビューター
- ペット予防医薬品の主要顧客

・ペット予防医薬品市場ダイナミクス
- ペット予防医薬品の業界動向
- ペット予防医薬品市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
Highlights
The global Preventive Medicine for Pets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Preventive Medicine for Pets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Preventive Medicine for Pets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Preventive Medicine for Pets include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Ouro Fino Saude, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Preventive Medicine for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventive Medicine for Pets.
The Preventive Medicine for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Preventive Medicine for Pets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preventive Medicine for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Segment by Type
Powder
Liquid
Segment by Application
Cat
Dog
Reptile
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preventive Medicine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preventive Medicine for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preventive Medicine for Pets Market Overview
1.1 Product Overview and Scope of Preventive Medicine for Pets
1.2 Preventive Medicine for Pets Segment by Type
1.2.1 Global Preventive Medicine for Pets Market Value Comparison by Type (2023-2029)
1.2.2 Powder
1.2.3 Liquid
1.3 Preventive Medicine for Pets Segment by Application
1.3.1 Global Preventive Medicine for Pets Market Value by Application: (2023-2029)
1.3.2 Cat
1.3.3 Dog
1.3.4 Reptile
1.3.5 Other
1.4 Global Preventive Medicine for Pets Market Size Estimates and Forecasts
1.4.1 Global Preventive Medicine for Pets Revenue 2018-2029
1.4.2 Global Preventive Medicine for Pets Sales 2018-2029
1.4.3 Global Preventive Medicine for Pets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Preventive Medicine for Pets Market Competition by Manufacturers
2.1 Global Preventive Medicine for Pets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Preventive Medicine for Pets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Preventive Medicine for Pets Average Price by Manufacturers (2018-2023)
2.4 Global Preventive Medicine for Pets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Preventive Medicine for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Preventive Medicine for Pets, Product Type & Application
2.7 Preventive Medicine for Pets Market Competitive Situation and Trends
2.7.1 Preventive Medicine for Pets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Preventive Medicine for Pets Players Market Share by Revenue
2.7.3 Global Preventive Medicine for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Preventive Medicine for Pets Retrospective Market Scenario by Region
3.1 Global Preventive Medicine for Pets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Preventive Medicine for Pets Global Preventive Medicine for Pets Sales by Region: 2018-2029
3.2.1 Global Preventive Medicine for Pets Sales by Region: 2018-2023
3.2.2 Global Preventive Medicine for Pets Sales by Region: 2024-2029
3.3 Global Preventive Medicine for Pets Global Preventive Medicine for Pets Revenue by Region: 2018-2029
3.3.1 Global Preventive Medicine for Pets Revenue by Region: 2018-2023
3.3.2 Global Preventive Medicine for Pets Revenue by Region: 2024-2029
3.4 North America Preventive Medicine for Pets Market Facts & Figures by Country
3.4.1 North America Preventive Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Preventive Medicine for Pets Sales by Country (2018-2029)
3.4.3 North America Preventive Medicine for Pets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Preventive Medicine for Pets Market Facts & Figures by Country
3.5.1 Europe Preventive Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Preventive Medicine for Pets Sales by Country (2018-2029)
3.5.3 Europe Preventive Medicine for Pets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Preventive Medicine for Pets Market Facts & Figures by Country
3.6.1 Asia Pacific Preventive Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Preventive Medicine for Pets Sales by Country (2018-2029)
3.6.3 Asia Pacific Preventive Medicine for Pets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Preventive Medicine for Pets Market Facts & Figures by Country
3.7.1 Latin America Preventive Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Preventive Medicine for Pets Sales by Country (2018-2029)
3.7.3 Latin America Preventive Medicine for Pets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Preventive Medicine for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Preventive Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Preventive Medicine for Pets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Preventive Medicine for Pets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Preventive Medicine for Pets Sales by Type (2018-2029)
4.1.1 Global Preventive Medicine for Pets Sales by Type (2018-2023)
4.1.2 Global Preventive Medicine for Pets Sales by Type (2024-2029)
4.1.3 Global Preventive Medicine for Pets Sales Market Share by Type (2018-2029)
4.2 Global Preventive Medicine for Pets Revenue by Type (2018-2029)
4.2.1 Global Preventive Medicine for Pets Revenue by Type (2018-2023)
4.2.2 Global Preventive Medicine for Pets Revenue by Type (2024-2029)
4.2.3 Global Preventive Medicine for Pets Revenue Market Share by Type (2018-2029)
4.3 Global Preventive Medicine for Pets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Preventive Medicine for Pets Sales by Application (2018-2029)
5.1.1 Global Preventive Medicine for Pets Sales by Application (2018-2023)
5.1.2 Global Preventive Medicine for Pets Sales by Application (2024-2029)
5.1.3 Global Preventive Medicine for Pets Sales Market Share by Application (2018-2029)
5.2 Global Preventive Medicine for Pets Revenue by Application (2018-2029)
5.2.1 Global Preventive Medicine for Pets Revenue by Application (2018-2023)
5.2.2 Global Preventive Medicine for Pets Revenue by Application (2024-2029)
5.2.3 Global Preventive Medicine for Pets Revenue Market Share by Application (2018-2029)
5.3 Global Preventive Medicine for Pets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zoetis Preventive Medicine for Pets Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Preventive Medicine for Pets Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Preventive Medicine for Pets Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elanco Preventive Medicine for Pets Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Preventive Medicine for Pets Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Corporation Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Dechra Veterinary Products Preventive Medicine for Pets Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Preventive Medicine for Pets Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Vetoquinol Preventive Medicine for Pets Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Ouro Fino Saude
6.9.1 Ouro Fino Saude Corporation Information
6.9.2 Ouro Fino Saude Description and Business Overview
6.9.3 Ouro Fino Saude Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ouro Fino Saude Preventive Medicine for Pets Product Portfolio
6.9.5 Ouro Fino Saude Recent Developments/Updates
6.10 Norbrook
6.10.1 Norbrook Corporation Information
6.10.2 Norbrook Description and Business Overview
6.10.3 Norbrook Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Norbrook Preventive Medicine for Pets Product Portfolio
6.10.5 Norbrook Recent Developments/Updates
6.11 Jindun
6.11.1 Jindun Corporation Information
6.11.2 Jindun Preventive Medicine for Pets Description and Business Overview
6.11.3 Jindun Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jindun Preventive Medicine for Pets Product Portfolio
6.11.5 Jindun Recent Developments/Updates
6.12 Wuhan chopperlvya
6.12.1 Wuhan chopperlvya Corporation Information
6.12.2 Wuhan chopperlvya Preventive Medicine for Pets Description and Business Overview
6.12.3 Wuhan chopperlvya Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Wuhan chopperlvya Preventive Medicine for Pets Product Portfolio
6.12.5 Wuhan chopperlvya Recent Developments/Updates
6.13 CAHIC
6.13.1 CAHIC Corporation Information
6.13.2 CAHIC Preventive Medicine for Pets Description and Business Overview
6.13.3 CAHIC Preventive Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CAHIC Preventive Medicine for Pets Product Portfolio
6.13.5 CAHIC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Preventive Medicine for Pets Industry Chain Analysis
7.2 Preventive Medicine for Pets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Preventive Medicine for Pets Production Mode & Process
7.4 Preventive Medicine for Pets Sales and Marketing
7.4.1 Preventive Medicine for Pets Sales Channels
7.4.2 Preventive Medicine for Pets Distributors
7.5 Preventive Medicine for Pets Customers
8 Preventive Medicine for Pets Market Dynamics
8.1 Preventive Medicine for Pets Industry Trends
8.2 Preventive Medicine for Pets Market Drivers
8.3 Preventive Medicine for Pets Market Challenges
8.4 Preventive Medicine for Pets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Preventive Medicine for Pets Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Preventive Medicine for Pets Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Preventive Medicine for Pets Market Competitive Situation by Manufacturers in 2022
Table 4. Global Preventive Medicine for Pets Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Preventive Medicine for Pets Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Preventive Medicine for Pets Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Preventive Medicine for Pets Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Preventive Medicine for Pets Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Preventive Medicine for Pets, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Preventive Medicine for Pets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Preventive Medicine for Pets, Product Type & Application
Table 12. Global Key Manufacturers of Preventive Medicine for Pets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Preventive Medicine for Pets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventive Medicine for Pets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Preventive Medicine for Pets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Preventive Medicine for Pets Sales by Region (2018-2023) & (K Units)
Table 18. Global Preventive Medicine for Pets Sales Market Share by Region (2018-2023)
Table 19. Global Preventive Medicine for Pets Sales by Region (2024-2029) & (K Units)
Table 20. Global Preventive Medicine for Pets Sales Market Share by Region (2024-2029)
Table 21. Global Preventive Medicine for Pets Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Preventive Medicine for Pets Revenue Market Share by Region (2018-2023)
Table 23. Global Preventive Medicine for Pets Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Preventive Medicine for Pets Revenue Market Share by Region (2024-2029)
Table 25. North America Preventive Medicine for Pets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Preventive Medicine for Pets Sales by Country (2018-2023) & (K Units)
Table 27. North America Preventive Medicine for Pets Sales by Country (2024-2029) & (K Units)
Table 28. North America Preventive Medicine for Pets Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Preventive Medicine for Pets Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Preventive Medicine for Pets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Preventive Medicine for Pets Sales by Country (2018-2023) & (K Units)
Table 32. Europe Preventive Medicine for Pets Sales by Country (2024-2029) & (K Units)
Table 33. Europe Preventive Medicine for Pets Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Preventive Medicine for Pets Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Preventive Medicine for Pets Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Preventive Medicine for Pets Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Preventive Medicine for Pets Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Preventive Medicine for Pets Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Preventive Medicine for Pets Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Preventive Medicine for Pets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Preventive Medicine for Pets Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Preventive Medicine for Pets Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Preventive Medicine for Pets Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Preventive Medicine for Pets Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Preventive Medicine for Pets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Preventive Medicine for Pets Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Preventive Medicine for Pets Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Preventive Medicine for Pets Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Preventive Medicine for Pets Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Preventive Medicine for Pets Sales (K Units) by Type (2018-2023)
Table 51. Global Preventive Medicine for Pets Sales (K Units) by Type (2024-2029)
Table 52. Global Preventive Medicine for Pets Sales Market Share by Type (2018-2023)
Table 53. Global Preventive Medicine for Pets Sales Market Share by Type (2024-2029)
Table 54. Global Preventive Medicine for Pets Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Preventive Medicine for Pets Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Preventive Medicine for Pets Revenue Market Share by Type (2018-2023)
Table 57. Global Preventive Medicine for Pets Revenue Market Share by Type (2024-2029)
Table 58. Global Preventive Medicine for Pets Price (US$/Unit) by Type (2018-2023)
Table 59. Global Preventive Medicine for Pets Price (US$/Unit) by Type (2024-2029)
Table 60. Global Preventive Medicine for Pets Sales (K Units) by Application (2018-2023)
Table 61. Global Preventive Medicine for Pets Sales (K Units) by Application (2024-2029)
Table 62. Global Preventive Medicine for Pets Sales Market Share by Application (2018-2023)
Table 63. Global Preventive Medicine for Pets Sales Market Share by Application (2024-2029)
Table 64. Global Preventive Medicine for Pets Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Preventive Medicine for Pets Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Preventive Medicine for Pets Revenue Market Share by Application (2018-2023)
Table 67. Global Preventive Medicine for Pets Revenue Market Share by Application (2024-2029)
Table 68. Global Preventive Medicine for Pets Price (US$/Unit) by Application (2018-2023)
Table 69. Global Preventive Medicine for Pets Price (US$/Unit) by Application (2024-2029)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Zoetis Preventive Medicine for Pets Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Boehringer Ingelheim Preventive Medicine for Pets Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Merck Preventive Medicine for Pets Product
Table 84. Merck Recent Developments/Updates
Table 85. Elanco Corporation Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Elanco Preventive Medicine for Pets Product
Table 89. Elanco Recent Developments/Updates
Table 90. Virbac Corporation Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Virbac Preventive Medicine for Pets Product
Table 94. Virbac Recent Developments/Updates
Table 95. Dechra Veterinary Products Corporation Information
Table 96. Dechra Veterinary Products Description and Business Overview
Table 97. Dechra Veterinary Products Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Dechra Veterinary Products Preventive Medicine for Pets Product
Table 99. Dechra Veterinary Products Recent Developments/Updates
Table 100. Ceva Corporation Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Ceva Preventive Medicine for Pets Product
Table 104. Ceva Recent Developments/Updates
Table 105. Vetoquinol Corporation Information
Table 106. Vetoquinol Description and Business Overview
Table 107. Vetoquinol Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Vetoquinol Preventive Medicine for Pets Product
Table 109. Vetoquinol Recent Developments/Updates
Table 110. Ouro Fino Saude Corporation Information
Table 111. Ouro Fino Saude Description and Business Overview
Table 112. Ouro Fino Saude Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Ouro Fino Saude Preventive Medicine for Pets Product
Table 114. Ouro Fino Saude Recent Developments/Updates
Table 115. Norbrook Corporation Information
Table 116. Norbrook Description and Business Overview
Table 117. Norbrook Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Norbrook Preventive Medicine for Pets Product
Table 119. Norbrook Recent Developments/Updates
Table 120. Jindun Corporation Information
Table 121. Jindun Description and Business Overview
Table 122. Jindun Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Jindun Preventive Medicine for Pets Product
Table 124. Jindun Recent Developments/Updates
Table 125. Wuhan chopperlvya Corporation Information
Table 126. Wuhan chopperlvya Description and Business Overview
Table 127. Wuhan chopperlvya Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Wuhan chopperlvya Preventive Medicine for Pets Product
Table 129. Wuhan chopperlvya Recent Developments/Updates
Table 130. CAHIC Corporation Information
Table 131. CAHIC Description and Business Overview
Table 132. CAHIC Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. CAHIC Preventive Medicine for Pets Product
Table 134. CAHIC Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Preventive Medicine for Pets Distributors List
Table 138. Preventive Medicine for Pets Customers List
Table 139. Preventive Medicine for Pets Market Trends
Table 140. Preventive Medicine for Pets Market Drivers
Table 141. Preventive Medicine for Pets Market Challenges
Table 142. Preventive Medicine for Pets Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Preventive Medicine for Pets
Figure 2. Global Preventive Medicine for Pets Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Preventive Medicine for Pets Market Share by Type in 2022 & 2029
Figure 4. Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Preventive Medicine for Pets Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Preventive Medicine for Pets Market Share by Application in 2022 & 2029
Figure 8. Cat
Figure 9. Dog
Figure 10. Reptile
Figure 11. Other
Figure 12. Global Preventive Medicine for Pets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Preventive Medicine for Pets Market Size (2018-2029) & (US$ Million)
Figure 14. Global Preventive Medicine for Pets Sales (2018-2029) & (K Units)
Figure 15. Global Preventive Medicine for Pets Average Price (US$/Unit) & (2018-2029)
Figure 16. Preventive Medicine for Pets Report Years Considered
Figure 17. Preventive Medicine for Pets Sales Share by Manufacturers in 2022
Figure 18. Global Preventive Medicine for Pets Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Preventive Medicine for Pets Players: Market Share by Revenue in 2022
Figure 20. Preventive Medicine for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Preventive Medicine for Pets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Preventive Medicine for Pets Sales Market Share by Country (2018-2029)
Figure 23. North America Preventive Medicine for Pets Revenue Market Share by Country (2018-2029)
Figure 24. United States Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Preventive Medicine for Pets Sales Market Share by Country (2018-2029)
Figure 27. Europe Preventive Medicine for Pets Revenue Market Share by Country (2018-2029)
Figure 28. Germany Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Preventive Medicine for Pets Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Preventive Medicine for Pets Revenue Market Share by Region (2018-2029)
Figure 35. China Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Preventive Medicine for Pets Sales Market Share by Country (2018-2029)
Figure 45. Latin America Preventive Medicine for Pets Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Preventive Medicine for Pets Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Preventive Medicine for Pets Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Preventive Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Preventive Medicine for Pets by Type (2018-2029)
Figure 55. Global Revenue Market Share of Preventive Medicine for Pets by Type (2018-2029)
Figure 56. Global Preventive Medicine for Pets Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Preventive Medicine for Pets by Application (2018-2029)
Figure 58. Global Revenue Market Share of Preventive Medicine for Pets by Application (2018-2029)
Figure 59. Global Preventive Medicine for Pets Price (US$/Unit) by Application (2018-2029)
Figure 60. Preventive Medicine for Pets Value Chain
Figure 61. Preventive Medicine for Pets Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ペット用ベジタリアンフードの世界市場2023年：ドライフード、ウェットフード
  • ペット用NSAIDのグローバル市場展望 2023年-2029年：注射型、経口型、その他
  • ペット用手術ハサミのグローバル市場展望 2023年-2029年：直ハサミ、カーブハサミ
  • ペット用手術器具のグローバル市場展望 2023年-2029年：手術針、手術用ハサミ、手術用パック、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA6651 )"ペット予防医薬品の世界市場2023年：粉末、液体" (英文：Global Preventive Medicine for Pets Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。